Hyuga Primary Care (7133) · RiskRestated
Risk of intensifying competition in home-visit pharmacies and partner-pharmacy support services
First written in FY2022. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Intensifying competition in the home healthcare and home-visit nursing marketA theme 3 companies write about · 3 as a headwind · 0 as a tailwind
2 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「Our group’s strengths include the home-visit expertise it has built up and the internally developed systems tailored to that expertise. However, if competition intensifies with the entry of new operators, this may affect our group’s performance.」
While home-visit expertise and internally developed systems are identified as strengths, the risk of intensifying competition from new entrants continues to be disclosed. - FY2022First statedAnnual report
「However, if competition intensifies with the entry of new operators, this may affect our performance.」
While expertise in home visits and internally developed systems are identified as strengths, intensifying competition from new entrants is identified as a risk.